U.S. market Closed. Opens in 17 hours 15 minutes

CCM | Concord Medical Services Holdings Limited Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue537.40M472.08M485.63M223.01M198.36M190.90M330.98M455.04M616.49M606.88M980.63M662.35M450.12M389.52M292.44M171.79M
Cost of Revenue614.01M624.49M542.53M209.93M214.19M171.14M232.98M286.54M353.34M274.56M586.95M337.20M159.42M122.70M87.56M45.60M
Gross Profit-76.61M-152.41M-56.90M13.08M-15.83M19.76M98.00M168.50M263.15M332.32M393.69M325.14M290.71M266.82M204.88M126.19M
Operating Expenses386.38M372.64M401.42M320.58M345.38M313.57M281.25M276.00M245.77M148.67M212.96M115.23M118.08M87.16M37.50M24.37M
Selling, General & Admin386.38M372.64M401.42M320.58M345.38M313.57M281.25M276.00M245.77M148.67M212.96M125.67M118.08M87.16M37.50M24.37M
Research & DevelopmentN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses-10.84M-216.61M-1.22M6.31M37.14M34.21MN/AN/AN/AN/AN/A-10.43MN/AN/AN/AN/A
Operating Income-462.99M-525.05M-458.32M-307.50M-437.29M-299.24M-211.86M-168.63M17.38M183.65M180.73M209.91M172.63M179.67M167.38M101.83M
Other Expenses / Income62.23M-314.85M-70.92M-134.15M46.22M100.63M-42.04M-35.97M-22.64M-8.00M-13.65M-13.25M-337.66M-4.88M-6.16M578.00K
Before Tax Income-555.59M-839.90M-529.24M-441.65M-391.08M-225.25M-253.90M-204.60M-5.25M175.65M167.08M196.67M-165.03M174.79M161.22M102.40M
Income Tax Expenses-24.57M-70.91M-6.57M-37.62M-38.99M34.05M31.79M60.49M74.03M80.85M75.88M62.19M46.32M43.87M36.40M23.34M
Net Income-297.66M-489.66M-820.62M-669.91M-552.53M-234.88M-284.32M-261.87M-78.30M124.71M85.89M130.83M-215.00M129.40M124.83M79.07M
Interest Expenses165.67M120.36M73.79M81.36M28.70M46.23M89.96M89.33M53.21M53.47M47.03M16.25M6.45M7.45M6.89M7.46M
Basic Shares Outstanding4.37M4.37M4.37M4.37M4.34M43.37M43.36M43.54M44.85M44.95M45.03M46.07M47.42M48.68M24.88M32.84M
Diluted Shares Outstanding4.37M4.37M4.37M4.37M4.34M43.37M43.36M43.54M44.85M45.06M45.03M46.07M47.42M48.68M24.88M32.84M
EBITDA-313.75M-581.17M-331.40M-206.43M-263.63M-211.56M-67.86M16.95M207.28M460.71M391.25M359.49M-41.59M290.41M246.29M147.99M
EBITDA Margin-58.38%-123.11%-68.24%-92.56%-132.90%-110.82%-20.50%3.73%33.62%75.91%39.90%54.27%-9.24%74.55%84.22%86.14%
EBIT-156.56M-440.21M-753.40M-626.17M-562.81M-154.59M-162.57M-112.05M48.94M259.03M208.80M209.27M-162.23M180.72M168.11M109.86M
EBIT Margin-29.13%-93.25%-155.14%-280.78%-283.73%-80.98%-49.12%-24.62%7.94%42.68%21.29%31.60%-36.04%46.40%57.49%63.95%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙